NEW YORK (GenomeWeb News) – 23andMe Co-founder Linda Avey has left the personal genomics services company to start a foundation that will focus on Alzheimer's disease. The foundation Avey will run will use the 23andMe research platform to search for causes of and treatments for the disease.
Avey's departure was effective as of Sept. 4, the day the announcement was made.
Avey and co-founder Anne Wojcicki started the company together around three years ago.
Mario Caccamo has been named head of bioinformatics for The Genome Analysis Centre in the UK. Caccamo worked until recently at the European Genome-Phenome Archive. The centre also recently appointed Amanda McMurray to be business development director.
DxS has appointed Patrik Dahlen to serve as a non-executive director. Dahlen formerly was CEO of cancer diagnostics firm Dako and CEO of BioImage, as well as president of life sciences and senior VP of PerkinElmer.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.